139 results on '"Pinguet, Frédéric"'
Search Results
2. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: Experimental study in a murine model of ovarian cancer
3. Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas
4. Pharmacology of EAPB0203, a novel imidazo[1,2- a]quinoxaline derivative with anti-tumoral activity on melanoma
5. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model
6. New imidazo[1,2- a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma
7. In vitro and in vivo anti-tumoral activities of imidazo[1,2- a]quinoxaline, imidazo[1,5- a]quinoxaline, and pyrazolo[1,5- a]quinoxaline derivatives
8. Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer
9. Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen
10. Biodistribution of doxorubicin-alkylated poly( l-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration
11. Docetaxel and Cisplatin in Patients With Metastatic Androgen Independent Prostate Cancer and Circulating Neuroendocrine Markers
12. Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies
13. Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen
14. Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer
15. Population pharmacokinetics of topotecan: intraindividual variability in total drug
16. Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags
17. Methyl-β-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin
18. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration
19. FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management
20. Complementary medicine and cancer: A French multicenter survey.
21. New advances in DPYD genotype and risk of severe toxicity under capecitabine
22. La nutrition artificielle : quelles prises en charge au domicile du patient ?
23. Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study
24. Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site.
25. Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic Exposure
26. A Universal Formula Based on Cystatin C to Perform Individual Dosing of Carboplatin in Normal Weight, Underweight, and Obese Patients
27. Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS
28. Impact médico-économique du docétaxel dans le traitement adjuvant du cancer du sein
29. A Phase I Dose-Escalating and Pharmacokinetic Study of Docetaxel and Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
30. Synthesis and Biological Evaluation of Indoloquinolines and Pyridocarbazoles: A New Example of Unexpected Photoreduction Accompanying Photocyclization
31. Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
32. Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer
33. Home parenteral nutrition: a direct cost study in approved centers of Montpellier and Strasbourg
34. Suivi thérapeutique pharmacologique du topotécan
35. Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen
36. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients
37. Gemcitabine and docetaxel as front‐line chemotherapy in patients with carcinoma of an unknown primary site
38. A Photochemical Approach to Pyridopyrroloquinoline Derivatives as New Potential Anticancer Agents
39. Sensitive HPLC-Fluorescence Method for Irinotecan and Four Major Metabolites in Human Plasma and Saliva: Application to Pharmacokinetic Studies
40. A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer
41. High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study
42. Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer
43. In vitroCytotoxic Activity of Three Essential Oils fromSalviaSpecies
44. High-performance liquid chromatographic assay for methyl-β-cyclodextrin in plasma and cell lysate
45. Economic evaluation of 4% albumin solution, gelatine, and hydroxyethylamidon for plasma volume expansion in cancer patients
46. High-performance liquid chromatographic assay for melphalan in human plasma Application to pharmacokinetic studies
47. High-performance liquid chromatographic determination of granisetron in human plasma
48. REACTIVITY OF 6,7,8,9-TETRAHYDROPYRIDO[1,2-a]BENZIMIDAZOL-9-ONE : SYNTHESIS OF PYRROLOPYRIDOBENZIMIDAZOLES.
49. Inter- and Intraindividual Variabilities in Pharmacokinetics of Fentanyl After Repeated 72-Hour Transdermal Applications in Cancer Pain Patients
50. Cytotoxicity of Iridals, Triterpenoids from Iris, on Human Tumor Cell Lines A2780 and K562
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.